Cargando…
Rapid lateral flow tests for the detection of SARS-CoV-2 neutralizing antibodies
Background: Rapid Lateral Flow Test (LFT) has been broadly utilized in detection or diagnosis of numerous disease-related antigens and antibodies. It is the most popular format of point-of-care test (POCT) and quickest and easiest way to detect a targeted molecule. In the combat against COVID-19 pan...
Autores principales: | Wang, Jianfu J., Zhang, Nan, Richardson, Sarah A., Wu, Jin V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054491/ https://www.ncbi.nlm.nih.gov/pubmed/33840347 http://dx.doi.org/10.1080/14737159.2021.1913123 |
Ejemplares similares
-
Evaluation of Two Rapid Lateral Flow Tests and Two Surrogate ELISAs for the Detection of SARS-CoV-2 Specific Neutralizing Antibodies
por: Girl, Philipp, et al.
Publicado: (2022) -
Evaluation of Simple Lateral Flow Immunoassays for Detection of SARS-CoV-2 Neutralizing Antibodies
por: Nickel, Olaf, et al.
Publicado: (2022) -
An update on lateral flow immunoassay for the rapid detection of SARS-CoV-2 antibodies
por: Spicuzza, Lucia, et al.
Publicado: (2023) -
Evaluation of Commercial Rapid Lateral Flow Tests, Alone or in Combination, for SARS-CoV-2 Antibody Testing
por: Fischer, Peter U., et al.
Publicado: (2021) -
Validation of a quantitative lateral flow immunoassay (LFIA)-based point-of-care (POC) rapid test for SARS-CoV-2 neutralizing antibodies
por: Pieri, Massimo, et al.
Publicado: (2022)